If you've spent any time reading about longevity, biohacking, or anti-aging medicine in the last few years, you've encountered three letters everywhere: NAD+. It shows up on supplement bottles, in IV bar menus, in podcasts featuring Stanford researchers, and in clinics that didn't exist five years ago. People are spending hundreds of dollars on infusions, thousands on supplements, and writing about feeling like they're 25 again.

So what is it, actually? Why does this single molecule have so much attention pinned to it? And how much of the conversation is real biology versus expensive marketing?

This is the field guide we wish existed when we first started looking into this. It explains what NAD+ is, why it matters, what happens as you age, what the research actually shows about the leading interventions, and how to think about NAD+ protocols without getting swept up in either the hype or the skepticism.

The short answer

NAD+ stands for nicotinamide adenine dinucleotide. It's a coenzyme found in every living cell. Without it, your cells cannot turn food into energy, repair damaged DNA, or run the cleanup systems that keep aging in check. NAD+ levels drop steadily as you age, by roughly half between young adulthood and middle age in many tissues. That decline is correlated with most of the things people associate with getting older: lower energy, slower recovery, more inflammation, declining metabolic flexibility, and reduced cellular resilience.

The longevity hypothesis, which is now backed by a growing pile of mouse studies and a smaller pile of human studies, is straightforward. If we could maintain NAD+ at youthful levels, we might delay or reduce some of the symptoms of aging. Whether the existing interventions (NMN, NR, IV infusions, injectable NAD+) actually do this in humans, and what downstream health effects follow, is where the real debate lives.

What NAD+ actually does, in plain English

Every cell in your body is constantly doing work. Muscle cells contract. Liver cells process metabolites. Neurons fire. Immune cells patrol. All of this work requires energy, and that energy comes from a tiny molecular battery called ATP. Producing ATP is the job of your mitochondria, the small organelles that live by the hundreds or thousands inside each of your cells.

NAD+ is the molecule that makes the mitochondrial energy production process possible. It's not the energy itself. It's the electron carrier that shuttles fuel through the chain of chemical reactions that ultimately produces ATP. Without enough NAD+, mitochondria slow down. With slower mitochondria, you have less cellular energy. With less cellular energy, every system that depends on that energy starts to underperform.

But energy production is only one of NAD+'s jobs. It also powers an entire family of enzymes called sirtuins, which act like the cell's quality-control team. Sirtuins repair damaged DNA, regulate inflammation, control circadian rhythm, and switch genes on and off depending on what the cell needs. They cannot function without NAD+. When NAD+ falls, sirtuin activity falls with it.

NAD+ also fuels PARP enzymes, which are your cells' DNA damage emergency responders. Every day, your DNA accumulates thousands of small breaks and errors from normal metabolism, UV exposure, and oxidative stress. PARPs repair them. PARPs need NAD+ to work.

So when researchers talk about NAD+ as central to aging, they aren't being dramatic. It really is involved in nearly every process that defines what it means for a cell to function. Energy production. DNA repair. Gene expression. Inflammation control. Metabolic flexibility. Take it down, and a lot goes down with it.

Why NAD+ levels fall as we age

This is the part of the story that turned NAD+ into a longevity target rather than a niche biochemistry topic. Research published in Cell Metabolism and other peer-reviewed journals shows that NAD+ levels in human tissue drop by roughly 50% between young adulthood and middle age. By your 60s and 70s, levels in some tissues are 20 to 30% of what they were when you were 20.

The drop happens for several reasons. The body's recycling pathways that regenerate NAD+ become less efficient. Chronic inflammation increases activity of an enzyme called CD38, which degrades NAD+ at a higher rate. Mitochondrial dysfunction itself reduces NAD+ production. And the genes that govern NAD+ biosynthesis show reduced expression with age.

The result is a slow, compounding decline. NAD+ falls. Mitochondria struggle. Sirtuins underperform. DNA repair slows. Inflammation climbs. Each of those, in turn, contributes to further NAD+ depletion. It's a downward spiral that maps onto a lot of what we recognize as aging biology.

How researchers think about restoring NAD+

You can't just take NAD+ in a pill. The molecule is too large and too unstable to survive digestion intact. So the strategy has been to use precursors: smaller molecules that your cells can convert into NAD+ through the natural biosynthesis pathway.

The three main precursors that have reached widespread availability are:

NR (nicotinamide riboside). A precursor that enters cells through dedicated transporters and then converts to NMN inside the cell, then to NAD+. NR has the most published human clinical trial data of any oral NAD+ precursor and reliably raises blood NAD+ levels at doses around 300 to 1000 mg per day.

NMN (nicotinamide mononucleotide). One step closer to NAD+ in the salvage pathway than NR. NMN became famous largely because David Sinclair, the Harvard longevity researcher, has been publicly taking it for years. Recent head-to-head human studies have shown NMN and NR both raise blood NAD+ effectively, with some studies showing NR has a slight edge and others suggesting NMN is comparable or better.

Nicotinamide (Nam) and niacin (NA). Older, well-characterized vitamin B3 forms. Niacin reliably raises NAD+ but causes a strong flushing reaction at effective doses. Nicotinamide on its own appears to raise NAD+ only acutely without sustained elevation.

Beyond oral precursors, there are also injectable approaches that bypass the gut entirely. NAD+ IV infusions deliver the molecule directly into circulation, achieving the highest possible bioavailability but requiring clinical administration and significant time. Subcutaneous and intramuscular NAD+ injections are a middle ground: more bioavailable than oral, more convenient than IV, and increasingly used in physician-supervised protocols.

What the human research actually shows

Here is where it gets honest. The mouse studies on NAD+ precursors are remarkable. Aged mice given NMN or NR show improvements in mitochondrial function, exercise capacity, insulin sensitivity, neurological function, and in some studies, extended lifespan. The biology in animals is striking enough that it's hard to read the papers and not get excited.

The human picture is more measured. What's well established in human trials:

What's not yet established in humans:

This isn't a reason for nihilism. It's an accurate description of where the field stands in 2026. The biology is well-grounded. The animal data is striking. The early human signals are positive but small. Large-scale, long-term human trials are underway and reading out in stages.

What about NAD+ injections and IV infusions?

This is where the debate gets sharpest. Injectable NAD+ bypasses the gut entirely, so on paper the bioavailability is dramatically higher than any oral precursor. A 2023 pharmacokinetic study found that IV NAD+ produced peak plasma NAD+ levels roughly six times higher than matched oral dosing.

The case for injectable NAD+: pharmacokinetically, it does what oral forms can't, hitting blood concentrations that simply aren't accessible through digestion. People who use it consistently report meaningful improvements in energy, mental clarity, sleep, and recovery, and clinical protocols for addiction recovery have shown high-dose IV NAD+ may help with withdrawal symptoms.

The case for skepticism: some leading researchers, including Dr. Eric Verdin of the Buck Institute for Research on Aging, have argued that the NAD+ molecule may be too large to enter cells directly and may be broken down into nicotinamide before it can act intracellularly. Whether the dramatic plasma elevations from injection actually translate into elevated intracellular NAD+ in tissues that matter is genuinely contested.

The honest synthesis: injectable NAD+ produces effects in many users that oral precursors don't, the mechanistic explanations for those effects are still being worked out, and the right answer for any individual depends on goals, budget, and access to clinical supervision. It's not a substitute for the foundational health behaviors. It can be a useful tool inside a broader protocol.

What else affects your NAD+ levels?

Long before you spend money on supplements or injections, there are foundational behaviors that have direct effects on NAD+:

Exercise. Especially resistance training and high-intensity intervals. Exercise stimulates NAD+ biosynthesis and improves mitochondrial function. The effect is consistent across multiple studies.

Caloric restriction and intermittent fasting. Both increase NAD+ levels and activate sirtuins. Periods of metabolic stress in the absence of food shift the body into NAD+-conserving and NAD+-producing modes.

Sleep. NAD+ cycles with the circadian clock. Poor sleep disrupts NAD+ rhythms and reduces overall levels. Consistent sleep schedules support consistent NAD+ biology.

Sun exposure (in moderation). UV damage drives NAD+ consumption by PARP enzymes. Heavy sun exposure depletes NAD+. Moderate, sensible exposure is fine; chronic overexposure is one of the bigger lifestyle drains on NAD+.

Alcohol. Heavy alcohol consumption is a NAD+ sink. The metabolism of alcohol consumes NAD+ at significant rates. Chronic heavy drinkers often have depressed NAD+ levels.

Diet. Foods naturally rich in NAD+ precursors include milk, edamame, fish, mushrooms, and avocado. Dietary contributions are modest compared to supplementation but not zero.

Who might benefit most from NAD+ protocols

The framework most longevity-focused clinicians use looks something like this:

NAD+ interventions make the most sense for people who have addressed the foundational drivers first (exercise, sleep, nutrition, stress) and want to add a targeted intervention that supports cellular energy and resilience. They make more sense for adults over 40, when natural NAD+ decline begins to accelerate. They make particular sense for people with high metabolic demand (athletes, shift workers, those recovering from illness or surgery) or those with measurable indicators of mitochondrial dysfunction.

NAD+ interventions make less sense as a first move for younger adults whose baseline levels are still high, or as a substitute for sleep, exercise, and nutrition fixes. They're an addition, not a replacement.

And critically: any injectable NAD+ protocol should be done under medical supervision. Dosing, frequency, and the specific format (subcutaneous versus IV) all matter, and a licensed provider can monitor your response and adjust accordingly.

Frequently asked questions

Is NAD+ the same as NMN or NR? No. NAD+ is the final coenzyme. NMN and NR are precursors that your body converts to NAD+. You cannot effectively supplement NAD+ directly through oral routes, which is why most products use precursors.

How quickly do you feel NAD+ supplementation? Most people report no immediate sensation from oral NMN or NR. Some report subtle improvements in energy or sleep within a few weeks. Injectable forms often produce more rapid subjective effects, often within hours of dosing.

Is NAD+ safe? Both oral precursors and supervised injectable protocols have shown strong safety profiles in clinical trials and real-world use. As with any intervention, individual response varies and supervision matters more at higher doses.

What dose is right? Common oral NR doses are 300 to 1000 mg per day. Common oral NMN doses range similarly. Injectable protocols are typically 100 to 200 mg subcutaneously per dose, two to three times weekly, under provider direction. There is no single right number; the right protocol depends on your goals, baseline, and clinical supervision.

How long do I need to be on it? NAD+ decline is a continuous process of aging. Most clinicians treat NAD+ optimization as a long-term protocol, similar to other lifestyle and supplementation strategies aimed at healthspan.

The Bottom Line

NAD+ is one of the most fundamental molecules in human biology. It powers your mitochondria, repairs your DNA, and activates the enzymes that defend against aging. Levels drop with age, and the leading hypothesis in longevity medicine is that maintaining youthful NAD+ may delay some aspects of cellular aging. The evidence is strongest in mice, growing in humans, and best understood as part of a broader healthspan strategy that includes exercise, sleep, nutrition, and provider-guided supplementation.

If you're considering a NAD+ protocol, CLYR Health offers physician-supervised NAD+ injections as part of our longevity catalog, with licensed providers, clinical pharmacy, and transparent pricing. Start your assessment.